Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06608173 · ClinicalTrials.gov registry record · NA

Evaluation of radKIDS 2.0, a Multi-media Training Program for Elementary School Bullying and Abuse Prevention

A NA study of Healthy and Self Efficacy, sponsored by Saavsus.

Active
Registry status
NA
Development phase
656
Enrollment target
2
Study locations

NCT06608173: Active NA study of Healthy and Self Efficacy, sponsored by Saavsus.

NCT06608173 is a NA study of Healthy and Self Efficacy that is active but no longer recruiting, run by Saavsus. The registered enrollment target is 656 participants, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06608173, a NA study of Healthy and Self Efficacy, is active but no longer recruiting, sponsored by Saavsus.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
656 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to evaluate an adapted version of the radKIDS® Personal Empowerment and Safety Education Program in randomly assigned 4th grade classrooms. The primary hypothesis is that students in the radKIDS study arm will have significantly higher growth in safety knowledge, safety skill self-efficacy, confidence in help-seeking and in maintaining personal safety, and self-esteem compared to classrooms in the business as usual condition. At the student level, researchers will compare 4th grade students in classrooms randomized to receive the radKIDS program to those in classrooms receiving their regular instruction. Student participants will complete two surveys a few months apart assessing safety knowledge, self-efficacy, and self-esteem. In the radKIDS2.0 arm, students will receive the radKIDS program between the two surveys. In the control arm, students will receive instruction as usual.

Primary Outcome

Provides a complete picture of self-concept using a simple yes-or-no response format. Students will complete three sub-scales: (1) Happiness and Satisfaction (10 items), (2) Freedom from Anxiety (14 items), and (3) Behavioral Adjustment (14 items). Response options are No = 1 and Yes = 2. Items will be scored and summed such that a higher score indicates a higher self-concept. The summed score range on the Happiness and Satisfaction sub-scale is 10 (min) to 20 (max) and the summed score range on

Interventions

  • BEHAVIORAL radKIDS2.0 Safety and Empowerment Education Program

Study Locations (2)

Oregon

  • Saavsus, Inc. - Eugene
  • Oregon Research Institute - Springfield

Trial Details

FieldValue
Enrollment Target 656 participants
Start Date 2024-06-04
Est. Completion 2025-06-30
Phase NA
Saavsus

2 total trials

What the registry record for NCT06608173 still lists

NCT06608173 is an interventional study that assigns participants to a tested intervention. The registered 656 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target.

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which radKIDS2.0 Safety and Empowerment Education Program is the first listed.

NCT06608173 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT06608173 about?

NCT06608173 is a clinical study titled "Evaluation of radKIDS 2.0, a Multi-media Training Program for Elementary School Bullying and Abuse Prevention". The goal of this clinical trial is to evaluate an adapted version of the radKIDS® Personal Empowerment and Safety Education Program in randomly assigned 4th grade classrooms. The primary hypothesis is that students in the radKIDS study arm will have significantly higher growth in safety knowledge, ...

What is the current status of trial NCT06608173?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 656 participants. The study started on 2024-06-04. Estimated completion is 2025-06-30.

What conditions does trial NCT06608173 study?

This clinical trial studies the following conditions: Healthy, Self Efficacy, Self Esteem, Knowledge.

What interventions are being tested in trial NCT06608173?

The interventions under investigation include: radKIDS2.0 Safety and Empowerment Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06608173?

This trial is sponsored by Saavsus, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06608173 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06608173's enrollment target sits among peer trials

656 40th of 1090 higher than 1,051 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05407129 · 656 participants · NA

    Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

  • NCT06127199 · 656 participants · NA

    Contraceptive Efficacy Study of Ovaprene

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • NCT05338697 · 657 participants

    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06608173, the US trial registry maintained by the National Library of Medicine. NCT06608173 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.